Adipokines as novel biomarkers and regulators of the metabolic syndrome
Key result
Adipokines function as active endocrine regulators and biomarkers, with their dysregulation implicated in obesity, type 2 diabetes, hypertension, and cardiovascular disease.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Adipokine assessment may refine cardiometabolic risk stratification; leaves open whether modulation improves outcomes in obesity-related CVD.
PICO
P
Population
Metabolic syndrome
E
Exposure / Comparator
Adipokines
This review highlights the role of adipokines as active endocrine regulators and potential therapeutic targets in metabolic syndrome and cardiovascular disease.
Cite This Study
Deng et al. (2010) conducted a review in Metabolic syndrome. Adipokines was evaluated. Adipokines function as active endocrine regulators and biomarkers, with their dysregulation implicated in obesity, type 2 diabetes, hypertension, and cardiovascular disease.